Kai-Keen Shiu (Kai Keen Shiu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Metastatic Colorectal Cancer

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Richard A Adams, David J Fisher, Janet Graham, Jenny F Seligmann, Matthew T Seymour, Richard S Kaplan, Emma Yates, Mahesh K B Parmar, Susan D Richman, Philip Quirke, Rachel Butler, Ewan Brown, Fiona Collinson, Stephen Falk, Harpreet S Wasan, Kai-Keen Shiu, Gary Middleton, Leslie M Samuel, Richard H Wilson, Louise C Brown, Timothy S Maughan, null null
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)